STEFAN OCTAVIAN CIUREA to Interleukin 1 Receptor Antagonist Protein
This is a "connection" page, showing publications STEFAN OCTAVIAN CIUREA has written about Interleukin 1 Receptor Antagonist Protein.
Connection Strength
0.053
-
Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis. Eur J Haematol. 2023 Sep; 111(3):477-484.
Score: 0.053
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.